Objective. To better understand the role of B cells, the potential mechanisms responsible for their aberrant activation, and the production of autoantibodies in the pathogenesis of Sj€ ogren's syndrome (SS), this study explored patterns of selection pressure and sites of Nglycosylation acquired by somatic mutation (acN-glyc) in the IgG variable (V) regions of antibody-secreting cells (ASCs) isolated from the minor salivary glands of patients with SS and non-SS control patients with sicca symptoms.
liferation of some autoreactive B cells, involving V-region N-glycosylation, in patients with SS. Sj€ ogren's syndrome (SS) is a systemic, chronic autoimmune disease that is characterized by lymphocytic infiltration of the exocrine glands, inflammation, tissue damage, and secretory dysfunction. Typically, the lacrimal and salivary glands are affected, resulting in dry eyes (keratoconjuntivitis sicca) and dry mouth (xerosomia), but patients can also present with extraglandular complications or overlapping autoimmune diseases (1) (2) (3) (4) (5) . In addition, patients with SS have an increased risk of progression to various non-Hodgkin's lymphomas (NHLs), resulting in significant morbidity (6) .
There is evidence to indicate that chronic immune cell stimulation by bacteria is an active mechanism in the development of NHLs not associated with SS (7) (8) (9) . It has been demonstrated that Pseudomonas aeruginosa and Burkholderia cenocepacia lectins bind to and activate B cells via B cell receptor variable (V)-region glycans (10) . Similarly, in a patient with SS-associated NHL, evidence of a bacterial etiology was observed with the regression of a parotid mucosa-associated lymphoid tissue lymphoma after clearance of the patient's Helicobacter pylori infection (11) .
It is known that dysregulation of both innate and adaptive immunity contributes to the etiology of SS and its complications; however, the pathophysiology of SS, as well as Sj€ ogren's-associated lymphoma, is largely unknown. B cells play a role in the pathogenesis of SS, as evidenced by the presence of autoantigen-specific memory B cells (12, 13) and the incidence of autoantibodies to Ro/SSA (Ro52 and Ro60) and La/SSB (14) . An abundance of evidence has demonstrated that there is antigen-driven production of autoantibodies within the salivary glands of patients with SS (13, 15, 16) . Ig V-region sequence analysis enables the identification of clonally expanded cells, serving as strong evidence of the antigen-driven activation and proliferation of B cells.
Antigen-driven activation can also be determined empirically by analyses of selection pressure in V-region sequences, in which the observed frequency of nonsynonymous (replacement) mutations is compared to their expected frequency in a state of no selection. When the frequency of replacement mutations is greater than expected, the Ig is considered to have undergone positive selection, and when the frequency is less than expected, negative selection is indicated. Typical antigen-driven activation results in positive selection in the complementarity-determining regions (CDRs), which directly interact with the antigen, and negative selection in the framework regions (FRs), which are important for structural integrity. Patterns of selective pressure contrary to this model indicate nonspecific activation.
Somatic hypermutations (SHMs) leading to amino acid replacements can also give rise to posttranslational modifications by the introduction of N-linked glycosylation (N-glyc) motifs. This results in SHM-acquired N-glyc (acN-glyc) of the antibody at these sites, and may have implications in immune responses or disease states. Ig Vregion acN-glyc motifs have been reported to be present in B cells from the parotid glands of patients with SS (17) and are strongly correlated with follicular lymphoma (18, 19) , a disease with a 4-fold increased incidence in patients with SS (20) . Instances of single Ig V-region N-glycans introduced by SHM have been demonstrated to either strengthen (21), weaken, or abolish binding of self or foreign antigens (22) . Conversely, bacterial or innate immune system lectins can bind V-region N-glycans, causing activation of B cells in an antigen-independent manner (10, 23) . Therefore, analyses of Ig V-region N-glycosylation may give clues with regard to the antibody-antigen interactions, tolerance mechanisms, and nonspecific modes of B cell activation that may drive proliferation of B cells in patients with SS.
In this study, we hypothesized that acN-glyc in the V regions of IgG antibody-secreting cells (ASCs) isolated from the labial salivary glands of patients with SS and non-SS control patients with dry mouth and dry eye (sicca symptoms) may provide opportunities for antigen-independent proliferation of autoreactive B cells and antibody production in the salivary glands of patients with SS. Our findings support this hypothesis, suggesting an alternative means by which B cell selection and proliferation of some autoreactive B cells may occur in patients with SS.
PATIENTS AND METHODS
Collection of labial salivary gland samples and evaluation of human subjects. Studies were approved by the Oklahoma Medical Research Foundation (OMRF) and University of Oklahoma Health Sciences Center Institutional Review Boards. Samples and data were obtained from all subjects following their provision of written informed consent. Participants were evaluated in the OMRF Sj€ ogren's Research Clinic (OSRC), as reported previously (24) . Labial salivary glands were collected for single-cell sorting and production of monoclonal antibodies (mAb), as previously described (16) . All 14 participants had symptoms of dry eyes and dry mouth, without a current diagnosis of, or history of, NHL. Of the 14 participants, 8 met the American-European Consensus Group classification criteria for primary SS (2), and 1 also met the American College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) (25, 26) . Six subjects with sicca symptoms who did not meet the classification criteria for SS served as non-SS controls.
Hematoxylin and eosin (H&E)-stained salivary gland sections were obtained from the OSRC repository, and 2 independent evaluations of the tissue sections for the presence of ectopic germinal center structures were made both by an oral pathologist and by a hematopathologist (DML and TAS). The demographic characteristics of the participants, classification criteria met, clinical/extraglandular manifestations, and disease activity scores based on the EULAR Sj€ ogren's Syndrome Disease Activity Index (ESSDAI) (with higher scores indicating a higher level of disease activity) (27) Production of recombinant mAb. Single-cell suspensions were stained for fluorescence-activated cell sorting, as previously described (16) . The recombinant mAb were produced from the labial salivary glands of 3 patients (1 patient with SS and SLE, and 2 patients with primary SS [patients pSS-1 and pSS-2 in Table 2 ]), using IgG and kappa gene primers, as previously described (29) . For the remaining subjects, the protocol was modified as described herein (see Supplementary Materials and Methods, available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40458/abstract). Variable (V), diversity (D), and joining (J) domains, FRs, and CDRs, along with the germline sequences, were identified using the International Immunogenetics Information System (IMGT/V-Quest) database.
To make the mutant mAb clones used in this study, Vregion genes cloned into expression vectors were subjected to site-directed mutagenesis using a Q5 site-directed mutagenesis kit (New England Biolabs), with nonoverlapping primers designed using the online tool NEBaseChanger (version 1.2.6; https://nebasechanger.neb.com). The mutated V genes were sequenced, amplified, and expressed in the same manner as described above.
Ig analyses for antigen-driven selection. The method known as BASELINe (i.e., Bayesian estimation of antigen-driven selection; http://clip.med.yale.edu/selection) can be used to detect and quantify antigen selection in individual or multiple sequences based on mutational patterns, normalized to germline sequences, and provides a visual representation of differences in selective pressure (30) . Clonally related sequences were identified by manual examination of the V-region genes recognized by the IMGT/V-Quest system, with confirmation using the Clonal Relate program (http://www.cse.unsw.edu.au/~ihmmune/Clona lRelate) (31) . To eliminate potential bias, we retained only the first randomly listed antibody in each of the clonal groups identified by ClonalRelate for the BASELINe analysis. The remaining productive heavy-and light-chain V-region sequences were then grouped (i.e., first by subject classification [SS or non-SS], and then by IgG allele [e.g., IGHV1-18*01, among others), and analyzed using BASELINe (version 1.3).
Ig heavy-and light-chain N-glycosylation motif analysis. Potential acN-glyc sites in the heavy-and light-chain V-region amino acid sequences were identified using the NetNGlyc web interface (http://www.cbs.dtu.dk/services/NetNGlyc/). N-glycosylation motifs were defined as previously described (32) . To confirm that all identified acN-glyc sites were introduced by SHM, sequences were compared to their germline counterparts. The translated sequences of clonally related V regions were analyzed using the online Clustal Omega multiple sequence alignment program (http://www.ebi.ac.uk/Tools/msa/ clustalo/) (33) . Clonal sequences were not removed, because we found that each could yield unique glycosylation patterns. We excluded any possible N-glyc sites with a potential significance of association of ≤0.5, or jury agreement of <5 of 9 (34).
Glycoprotein and specificity analyses of mAb. For analyses of mAb, 1.5 lg of mAb or bovine IgG control (EquitechBio) were incubated at 37°C overnight with or without PNGase F (New England Biolabs), and then electrophoresed on a 4-12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel (GenScript). For Coomassie blue staining, the gel was fixed in a destaining solution of 50% methanol and 10% acetic acid for 1 hour at room temperature, incubated for 1 hour with Coomassie brilliant blue (Bio-Rad), and then washed and destained with a destaining solution.
For analyses of lectin binding and immunoblotting of the mAb, samples were loaded onto a 4-12% SDS-PAGE gel (GenScript) and then electrophoresed, prior to transfer onto a cellulose membrane. For concanavalin A (Con A) staining, the membrane was blocked with a Tris buffered saline solution containing 0.05% Tween 20 (TBS-T) and 5% (weight/volume) bovine serum albumin (BSA) for 1 hour at room temperature, and then incubated with Con A-biotin (0.2 lg/ml) (Vector) in TBS-T with 1% BSA for 1 hour at room temperature, followed by incubation with streptavidin-horseradish peroxidase (HRP) (0.2 lg/ml) (Vector) in TBSTcontaining 1% BSA for 1 hour at room temperature. For human IgG staining, the membrane was incubated with peroxidase-labeled goat anti-human IgG (Fc) antibody (KPL) at 0.2 lg/ml in TBS-T with 5% BSA for 1 hour at room temperature, and then washed with TBS-T. Signals were detected using an HRP chemiluminescence substrate (SuperSignal West Pico Chemiluminescent Substrate; Thermo Scientific).
Enzyme-linked immunosorbent assays (ELISAs) for screening of nuclear antigens were performed on all mAb in a manner as previously described (16) .
Ig protein modeling. To visualize the location of the acN-glyc sites in the clonal set of mAb, we utilized the crystal structure of the human IgG1 molecule (PDB accession number 3EYQ, 2.4
A resolution) as a template for the HHPRED modeling server (https://toolkit.tuebingen.mpg.de/hhpred) (35) . The individual somatic mutations from mAb clone 2-E04k were inserted where appropriate, and a representative Fab FR3 complex-type biantennary N-glycan, as identified in another published study (36) , was modeled at the acN-glyc site using MAIN software (37) . The model graphics were created using PyMOL (PyMOL Molecular Graphics System, version 1.8.2; Schr€ odinger). 
* Subject identifiers refer to 3 patients with primary Sj€ ogren's syndrome (pSS) and 1 patient with sicca symptoms who did not meet the criteria for primary SS (non-SS control). † Clone has heavy-chain N-glycosylation acquired by somatic mutation (acN-glyc).
Statistical analysis. Fisher's exact tests were performed using GraphPad QuickCalcs (http://www.graphpad.com/quickcalc s/contingency1). GraphPad Prism software (version 7.0b) was used for the F test to compare variances, as well as for all parametric t-tests and nonparametric Mann-Whitney tests, which were each preceded by the D'Agostino and Pearson omnibus normality test.
RESULTS
Demographic and clinical characteristics of the participants. Evaluation of H&E-stained sections from the salivary gland biopsy tissue revealed that all patients with SS and non-SS controls had varying levels of chronic inflammation with lymphocytic infiltration (Table 1 ). In addition, 4 of the patients with SS (patients SS/SLE, pSS-1, pSS-2, and pSS-5 identified in Table 2 (28) .
Clonal expansions, secondary light-chain editing, and allelic inclusion, as revealed by Ig heavy-and lightchain sequence analyses. We cloned and sequenced a total of 122 productive IgG heavy-chain and kappa or lambda light-chain pairs from the ASCs of both groups. Of these, 100 pairs were from patients with SS (4 pairs from patient SS/SLE, 18 pairs from patient pSS-1, 23 pairs from patient pSS-2, 11 pairs from patient pSS-3, 36 pairs from patient pSS-4, 1 pair from patient pSS-5, 5 pairs from patient pSS-6, and 2 pairs from patient pSS-7), and 22 pairs were from non-SS controls (8 pairs from non-SS control subject 1, 6 pairs from non-SS control subject 2, 2 pairs from non-SS control subject 3, 1 pair from non-SS control subject 4, 4 pairs from non-SS control subject 5, and 1 pair from non-SS control subject 6). We identified several clonally related mAb. Of the patients with SS, patient pSS-1 had a single 5-member expansion, patient pSS-2 had a total of five 2-member expansions, and patient pSS-4 had a total of 5 expansions. There was 1 clonal pair identified in the sequences from non-SS control subject 2 ( Table 2) .
We found evidence of secondary light-chain editing in the sequences from patients pSS-2 and pSS-4 and non-SS control subject 2, indicated by the presence of clonally related heavy chains with differential light-chain usage (clonal, with light-chain replacement) ( Table 2 ). In addition, allelic inclusion, or 1 heavy chain with 2 distinct light chains within the same cell, was identified in 2 instances, in the ASCs from patient pSS-4 (clones 6-E01 and 6-E04) ( Table 2 ). In each case, both a kappa lightchain sequence and a lambda light-chain sequence were amplified from the same cell.
Whether analyzed with clonal sequences or without clonal sequences, the length of the heavy-chain CDR3 was greater in patients with SS than in non-SS controls (with clonal sequences, 17 amino acids versus 15.5 amino acids in length, respectively [P = 0.047]; without clonal sequences, 17 amino acids versus 15 amino acids in length, respectively [P = 0.048]). There were no differences between patients and controls in the lengths of the light-chain CDR3s (11 amino acids in length, with or without clones, in both groups) or in the number of amino acid replacements in the heavy or light chains.
Differential acquisition of V-region N-glycoslyation motifs between patients with SS and non-SS controls. All of the N-glyc motifs identified in the heavy-and light-chain V regions of patients and controls were not germline encoded, and therefore had been acquired via SHM (acNglyc). We identified acN-glyc motifs in sequences from 6 of 8 patients with SS (patients pSS/SLE, pSS-1, pSS-2, pSS-3, pSS-5, and pSS-6) and 2 of 6 non-SS controls (non-SS control subject 3 and non-SS control subject 5).
The acquisition of Fab N-glycosylation by SHM is a process that occurs in germinal centers. Therefore, we looked for correlations between the incidence of acNglyc and the presence of germinal centers in the salivary gland biopsy tissue. We found that in each of the 4 subjects identified with germinal center-like structures, all had V-region acN-glyc motifs, but not all subjects with Vregion acN-glyc motifs had germinal center-like structures in the glands examined. The incidence of acN-glyc in a heavy-chain/light-chain pair was more than doubled in sequences from patients with SS (29% [28 of 97] ) as compared to non-SS controls (9% [2 of 22]); however, these differences only trended toward statistical significance (P = 0.061).
We found a trend toward an increased number of acN-glyc sites in the FRs of sequences from patients with SS as compared to those from non-SS controls (22% [21 of 97] versus 5% [1 of 22], respectively; P = 0.072). In patients with SS, one-half (n = 11) of the FR acN-glyc motifs were located in FR1 of the heavy and light chains. There were no FR1 acN-glyc motifs in the non-SS control sequences. We found no instances of acN-glyc motifs in the CDR3 regions of heavy or light chains, and no differences in the number of CDR1/CDR2 acN-glyc motifs between patients with SS and non-SS controls (11 of 97 versus 3 of 22, respectively; P = 0.722).
Association of acN-glyc motifs with increased frequencies of SHM and amino acid replacements. We compared the heavy-and light-chain sequences that contained acN-glyc (n = 31) to those without acN-glyc (n = 91), without regard to disease classification ( Figures 1A-C Selection pressure patterns in the V regions of sequences from patients with SS compared to non-SS controls. We performed a BASELINe focused binomial test (30, 38, 39) on all of the unique sequences from patients with SS and non-SS controls, and found overall positive selection in the CDRs and negative selection in the FRs of the heavy chains from each group (for CDRs, P = 0.009 in patients with SS, P = 0.05 in non-SS controls; for FRs, P = 2.99 9 10 À7 in patients with SS, P = 0.02 in non-SS controls). We found no significant selection pressure in the light-chain CDRs of sequences either in patients with SS or in non-SS controls (P = 0.19 and P = 0.39, respectively). However, both in the light-chain sequences from patients with SS and in the light-chain sequences from non-SS controls, negative selection in the FRs was observed (P = 2.85 9 10 À14 and P = 4.46 9 10
À8
, respectively). When we compared all of the SS sequences with all of the non-SS sequences, we found no significant differences in the selection pressures in either the heavy-or light-chain CDRs or FRs between the 2 groups (Figure 2A Differential selection pressure patterns in Fab sequences with acN-glyc motifs. Since we found an increased frequency of acN-glyc motifs in the sequences from patients with SS, and since bacterial lectins have been reported to bind N-glycans and facilitate nonspecific B cell activation (10), we analyzed the effects of acN-glyc on selection pressure. We compared heavy-chain sequences that contained acN-glyc motifs to those without acN-glyc motifs, without regard to disease classification. Results of the BASELINe focused binomial test indicated differential CDR selection between the 2 groups, in which there was no selection in the CDRs from heavy chains with acN-glyc motifs (P = 0.41) but strong selection in the CDRs from heavy chains without acN-glyc motifs (P = 0.0007). All sequences, both those with and those without acN-glyc motifs, had negative selection in the FRs (P = 3.91 9 10
À5
and P = 5.6 9 10 À8 , respectively). When we compared the selection strengths of heavy chains with acN-glyc motifs to those without acNglyc motifs, we found that heavy chains with acN-glyc motifs showed a trend toward less positive selection in Figure 1 . Somatic hypermutations, replacement mutations, and amino acid (AA) changes in sequences in the presence or absence of regions of N-glycosylation acquired by somatic mutation (acN-glyc). Sequence analyses of variable (V) regions were performed in the minor salivary gland antibody-secreting cells from patients with Sj€ ogren's syndrome (SS) and non-SS control patients with sicca symptoms, in V regions with (n = 31) or without (n = 91) acN-glyc motifs. A, Number of heavy-and light-chain V-region somatic hypermutations. B, Number of heavy-and light-chain replacement mutations. C, Number of heavy-and light-chain V-region amino acid changes. Results are the mean AE SD. * = P < 0.05; ** = P < 0.01. NS = not significant. their CDRs (P = 0.0679) relative to the sequences without acN-glyc motifs ( Figure 2C) .
Clonally related mAb with differential FR1 acNglyc motifs. Our analyses of acN-glyc motifs also revealed a clonal set of differentially glycosylated Ig sequences (patient pSS-1, clone 1 in Table 2 ). A multiple alignment of the heavy-and light-chain amino acid sequences (Figure 3A) revealed that 3 of the heavy-chain translated sequences in the clones were identical (for clones 2-E04k, 3-C06k, and 4-A01k). Clone 2-C06k and 4-A01k also Figure 2 . Comparison of selection pressure differences between groups using the Bayesian estimation of antigen-driven selection (BASELINe) method. The histograms provide a visualization of selection pressures for the complementarity-determining regions (CDRs) (red lines) and framework regions (FRs) (blue lines). Overlays of both, indicating the differences between groups, are shown in the lower left quadrants, with solid lines representing the column variable (e.g., in A, non-Sj€ ogren's syndrome [SS] control patients with sicca symptoms) and broken lines representing the row variable (e.g., in A, patients with SS). Upper right quadrants show the statistically derived relative differences (determined with the binomial statistical test used by BASELINe) for each comparison, where the red boxes and positive numbers represent positive selection, and green boxes and negative numbers represent negative selection. Selection pressures in the heavy chains (A) and light chains (B) were compared between patients with SS and non-SS controls. Selection pressures in the heavy chains were also compared between those with N-glycosylation acquired by somatic mutation (acN-glyc) and those without acN-glyc (C).
shared an identical light-chain sequence. Clone 4-B03k was the only 1 of the 5 clonal immunoglobulins that did not have an acN-glyc at position 21 of the heavy chain (D21) in FR1.
To confirm that the FR1 (N21) N-glyc motifs in this clonal group could indeed be glycosylated at the protein level, the heavy-and light-chain V regions of the 5 pairs were cloned into expression vectors and expressed as mAb. Glycosylation studies were performed on mAb 4-A01k, 2-E04k, 4-G03k, and 4-B03k. Clone 3-C06k was not analyzed, as it was identical in amino acid sequence to clone 4-A01k ( Figure 3A) . After enzymatic removal of Nglycans with PNGase F and separation on an SDS-PAGE gel, staining with Coomassie brilliant blue showed that there was a motility shift in the heavy chain of the Ig molecules ( Figure 3B ), indicating that loss of N-glycans had occurred. The shift for clone 4-B03k, which lacked the FR1 N-glycan motif, was moderate compared to that for the other 3 clones, and comparable to that observed for bovine IgG, which was known to carry only 1 N-glycan per heavy chain. Staining with Con A, which binds mannose-containing N-glycans, confirmed the presence of N-glycans in the untreated sample, and demonstrated that the N-glycans were quantitatively removed after treatment with PNGase F.
Effect of FR1 N-glycoslyation on mAb antigen binding. To determine whether these clones were autoreactive, the mAb were tested by ELISA for binding Ro, La, Sm, and nuclear RNP (nRNP) ( Figure 3C ). All 5 clones had some degree of binding to all antigens, with 3-C06k, 4-A01k, and 4-G03k having the highest levels of reactivity.
We next determined the effects of N-glycosylation in the FR1 on antigen binding. We removed the acN-glyc motif from the FR1 of 3-C06k by replacing the asparagine (N) at position 21 with an aspartic acid (D) (N21D-3C06k). Conversely, we introduced an N-glyc motif to 4-B03k at the same position, converting the aspartic acid to an asparagine (D21N-4B03k). We expressed these mutant mAb and retested them for binding to Ro, La, Sm, and nRNP. We found that N21D-3C06k had almost completely lost all binding to all 4 antigens after removal of the FR1 N-glyc ( Figure 3D ). However, D21N-4B03k did not gain binding to any of the antigens after the addition of an N-glyc in FR1, but instead lost binding to La, Sm, and nRNP. Potential mechanism for FR1 acN-glyc participation in antigen binding via expansion of the antigenbinding site, as revealed by protein modeling. We used protein modeling of clone 2-E04k to visualize the location of the FR1 N-glyc in relation to the CDR antigen-binding pocket ( Figures 4A and B) . The heavy-chain FR1 acNglyc was oriented on the exterior of the molecule, very near the CDR binding site. We replaced the light chain in the model with the other light chains in the clonal group and found no appreciable difference in the orientation of the acN-glyc (data not shown).
To visualize how an N-glyc might affect or participate in antigen binding, we added and remodeled an FR3 complex, biantennary N-glycan structure (4FQC), as was previously identified in another study (36) , to our model ( Figure 4C ). We found that the binding surface could effectively be expanded by the close proximity of the branched carbohydrate structure ( Figure 4D ).
DISCUSSION
The non-SS controls used in this study were not healthy subjects, but unlike healthy controls, they had a sufficient number of ASCs for isolation by single-cell sorting, and therefore these subjects served as excellent sicca controls. Since the non-SS control subjects each had some degree of glandular inflammation (see Table 1 ), the differences seen between patients with SS and non-SS controls in this study could not be attributed to an inflammatory milieu or the lack thereof. It will be interesting to follow up the non-SS controls longitudinally to determine if some progression to SS takes place over time, or if these subjects represent a distinct disease or subset not yet defined.
The ASCs from the first 3 subjects enrolled into this study were interrogated using a previously published reverse transcription-polymerase chain reaction (RT-PCR) protocol (29) that limited the probing of each single-sorted cell with multiplexed primers for only 1 heavy-chain and 1 light-chain isotype. The modification of our protocol for the remaining subjects to a 2-step RT-PCR method enabled probing for multiple heavy-and light-chain isotypes. The utility of this method could also extend to any other expressed gene of interest in singlesorted cells from any B cell population. Our efforts revealed what appear to be rare cases of allelic inclusion in 1 of the patients with primary SS (patient pSS-4), which would not have been identified with the previous method. We are uncertain whether both light chains are translated and expressed with heavy chains in these cells, or whether they remain as remnant messenger RNA from earlier selection events. B cells that express dual light chains on their surface have been described in healthy humans (40) and in various B cell lymphomas (41) (42) (43) . The incidence of lymphoma is increased in SS, and it is possible that the dual light-chain ASCs that we identified are precursors to neoplastic lymphoblasts. Interestingly, patient pSS-4 was one of the patients who was also identified as having an increased probability of lymphoma development (28) .
Secondary light-chain replacement, or receptor revision as it is called in the periphery, has been demonstrated in both mice and humans (44, 45) . Receptor revision has also been reported in patients with SLE (46) and in the cerebral spinal fluid infiltrating B cells from patients with multiple sclerosis (47, 48) , but to our knowledge, this process has not been previously reported in patients with SS. These findings are not likely to be the result of PCR contamination, as each light-chain replacement was a unique sequence, not found paired with any other heavy chain in the study. Whether the light-chain replacements identified represent a novel peripheral tolerance mechanism is unknown.
Our finding of somatically mutated, clonally related ASCs in 3 patients with SS and 1 non-SS control may represent evidence that antigen-driven B cell proliferation occurs within the labial salivary glands, and is consistent with findings from our previous study (16) . The BASELINe analyses also supported this finding. A recent study by Hamza et al found no evidence for positive selection in SS parotid B cell heavy chains using the BASELINe method (17) , but this may be easily explained by differences in study designs. The Hamza study involved bulk RNA from parotid tissue B cells, instead of single cell-sorted labial salivary gland ASCs as in our study. They also probed only the IgG V H 3-family genes, whereas we included primers for all V H -family genes. Alternatively, there may be microenvironmental differences between the parotid gland and labial salivary gland tissue, or differences in B cell subsets, since memory B cells accumulate in the parotid tissue of patients with SS (49).
The increased incidence of acN-glyc motifs, particularly those occurring in the FRs, was interesting. Hamza and colleagues also reported an increased frequency of FR acN-glyc motifs in patients with SS. The increased rates of SHM in immunoglobulins with regions of acN-glyc suggest that acN-glyc motifs may drive SHM by facilitating increased activation signals via bacterial lectins, independent of antigen. This is supported by our finding that heavy chains with acN-glyc motifs did not indicate selection of the CDR antigen-binding regions, suggesting that there is an antigen-independent mechanism for their origin. Alternatively, the likelihood of acquiring novel N-glycosylation motifs may increase as the rate of SHM increases. It was interesting that we found evidence of salivary gland germinal center structures in only 4 of the patients with acN-glyc sites. This may be explained by the fact that these analyses were not performed in the same glands. Since the glands processed for single-cell sorting and mAb production/sequencing must be used in their entirety for the production of mAb, the germinal center analyses were performed on other glands biopsied at the same clinic visit.
Sequences with acN-glyc motifs have at least 1 replacement mutation leading to the acquisition of the N-glyc, so it is possible that we have introduced bias to this analysis by parsing them into acN-glyc-positive and acN-glyc-negative groups. However, BASELINe analysis predicts selection pressures by identifying replacement mutations that occur at higher rates than would be expected in a scenario of "no selection," and therefore we would expect any bias of this nature to have resulted in increased positive selection, but we observed the opposite, which supports our data and reinforces the idea of a nonspecific activation of these cells. Since bacterial lectins have been demonstrated to bind Ig N-glycans and trigger nonspecific activation of the B cell (10), this is a possible mechanism for a break in tolerance leading to Ig autoreactivity, as well as a potential mechanism for the increased risk of lymphoma seen in patients with SS.
After removing the FR1 acN-glyc from clone 3-C06k, binding to 4 common autoantigens was almost completely abolished, indicating that the acquisition of an N-glycan via SHM can actually increase binding to the self antigens that are commonly bound by mAb produced from the labial salivary glands of patients with SS (16) . Similar findings have been reported for a polyreactive mAb after removal of an FR3 N-glyc (50) . The heavy chain is only partially responsible for antigen affinity, and between the 5 clones there were 4 light chains with unique mutations, which could explain the lowered binding by both D21N-4B03k and 2-E04k. Oligosaccharides are inherently flexible, and individual sugar linkages can exist in various conformations (51) . The N-glycan conformation in our model is one possible, but hypothetical, conformation. In reality, the glycan at N21 probably freely explores the solvent space within its cone of rotation. In order for it to add surface area to the CDR3, it must be trapped in this conformation by stabilizing influences of the incoming antigen, or by antigen binding in those moments when the glycan stochastically occupies that space. Therefore, our model provides visual evidence of how glycan structures originating outside of the CDRs could affect antigen binding, depending on their placement, structure, and rotational conformations, by extending the surface of, or interfering with, the antigen-binding plane. This supports the possibility of either antigen-independent or codependent stimulation via lectin-glycan interactions, leading to B cell activation.
In summary, we have developed an improved method for the isolation and characterization of rare B cell populations and production of mAb from these cells, which provides data suggesting the possibility that peripheral tolerance mechanisms, which have not been previously reported, are active in the labial salivary gland ASCs of patients with SS. Overall, we found evidence of antigen-driven positive selection in these cells. However, our finding of reduced positive selection in ASCs harboring Ig acN-glyc motifs suggests that in patients with SS, there may be potential alternative mechanisms for the selection and hyperactivation of B cells as well as the proliferation of some of the autoreactive cells frequently seen in this disease.
